Company / Free Cash Flow
OptimizeRx Corp Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$4.8M
FY2025
5-year range
-$7.3M / $10.6M
FY2021-FY2025
Trend
+165.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from -$7M in FY2024 to $11M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +96.9%.
Declined from $11M to $5M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +96.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +96.9%, indicating consistent growth.
- In FY2025, free cash flow increased 165.2% year-over-year.
- Peak free cash flow was recorded in FY2023.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.8M | +165.2% |
| FY2024 | -$7.3M | -169.3% |
| FY2023 | $10.6M | +1589.8% |
| FY2022 | $625.7K | +109.8% |
| FY2021 | -$6.4M | -264.8% |
| FY2020 | -$1.7M | -330.6% |
| FY2019 | $758.2K | +149.8% |
| FY2018 | -$1.5M | -136.2% |
| FY2017 | -$644.4K | -225.6% |
| FY2016 | $513.1K | +910.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026